Gemini Therapeutics' Series A Round

Gemini Therapeutics raised a round of funding on October 17, 2017.

Gemini Therapeutics is a precision medicine company focused on genetically-defined dry age-related macular degeneration (AMD) and associated rare genetic diseases.…

Articles about Gemini Therapeutics' Series A Round: